Bioptimus Secures $76M Funding to Develop Revolutionary AI Foundation Model for Biology

Funding Milestone:
Bioptimus has reached a significant funding milestone of $76 million, including a recent $41 million cash injection led by Cathay Innovation12.

Mission:
The funding will accelerate Bioptimus’s mission to build the world’s first universal AI foundation model for biology, aimed at revolutionizing research and innovation across the medical, biotech, and cosmetic industries13.

Groundbreaking Model:
The new model will allow the simulation of biology at unprecedented scale and dimension, creating biological innovation by integrating data across multiple scales (molecules, cells, tissues, organisms) and modalities (imaging, genetics, etc)13.

Previous Success:
Bioptimus has already successfully released the largest AI foundation model for pathology, H-Optimus-0, which has outperformed all other pathology models in independent benchmarks12.

Investor Support:
The funding round includes participation from prominent investors such as Sofinnova Partners, Bpifrance, Andera Partners, Hitachi Ventures, Boom Capital Ventures, Pomifer Capital, Sunrise, and angel entrepreneurs Emmanuel Cassimatis and Thomas Wolf12.

Industry Impact:
The model is expected to empower researchers in the pharmaceutical industry to simulate complex biology, predict disease outcomes and response to treatment, and design therapies with unprecedented precision15.

Future Potential:
Beyond pharmaceuticals, the model will unlock limitless possibilities across many other industries, driving biological discoveries in ways that are only beginning to be imagined15.

Sources:

1. https://www.bioptimus.com/news/bioptimus-hits-76m-funding

2. https://siliconcanals.com/bioptimus-bags-74m/

3. https://www.anderapartners.com/en/bioptimus-hits-76m-funding-milestone-and-prepares-to-launch-groundbreaking-foundation-model-for-biology/

5. https://www.siliconrepublic.com/start-ups/bioptimus-paris-france-start-up-funding-ai-gpt-biology